DAWN
Price
$7.10
Change
-$0.13 (-1.80%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
719.67M
7 days until earnings call
RAPP
Price
$16.75
Change
+$0.62 (+3.84%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
610.97M
9 days until earnings call
Interact to see
Advertisement

DAWN vs RAPP

Header iconDAWN vs RAPP Comparison
Open Charts DAWN vs RAPPBanner chart's image
Day One Biopharmaceuticals
Price$7.10
Change-$0.13 (-1.80%)
Volume$74.3K
Capitalization719.67M
Rapport Therapeutics
Price$16.75
Change+$0.62 (+3.84%)
Volume$741
Capitalization610.97M
DAWN vs RAPP Comparison Chart in %
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. RAPP commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a StrongBuy and RAPP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (DAWN: $7.10 vs. RAPP: $16.74)
Brand notoriety: DAWN and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 119% vs. RAPP: 71%
Market capitalization -- DAWN: $719.67M vs. RAPP: $610.97M
DAWN [@Biotechnology] is valued at $719.67M. RAPP’s [@Biotechnology] market capitalization is $610.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 1 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • DAWN’s FA Score: 1 green, 4 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 6 TA indicator(s) are bullish while RAPP’s TA Score has 4 bullish TA indicator(s).

  • DAWN’s TA Score: 6 bullish, 4 bearish.
  • RAPP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than RAPP.

Price Growth

DAWN (@Biotechnology) experienced а +10.94% price change this week, while RAPP (@Biotechnology) price change was +16.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was +17.90%, and the average quarterly price growth was +45.83%.

Reported Earning Dates

DAWN is expected to report earnings on Nov 10, 2025.

RAPP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DAWN($720M) has a higher market cap than RAPP($611M). RAPP YTD gains are higher at: -5.637 vs. DAWN (-43.962). RAPP has higher annual earnings (EBITDA): -92.14M vs. DAWN (-188.76M). DAWN has more cash in the bank: 473M vs. RAPP (285M). DAWN has less debt than RAPP: DAWN (2.92M) vs RAPP (7.84M). DAWN has higher revenues than RAPP: DAWN (162M) vs RAPP (0).
DAWNRAPPDAWN / RAPP
Capitalization720M611M118%
EBITDA-188.76M-92.14M205%
Gain YTD-43.962-5.637780%
P/E RatioN/AN/A-
Revenue162M0-
Total Cash473M285M166%
Total Debt2.92M7.84M37%
TECHNICAL ANALYSIS
Technical Analysis
DAWNRAPP
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 6 days ago
90%
Declines
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITHIX44.87N/A
N/A
Hartford Capital Appreciation I
GCVAX24.55N/A
N/A
Goldman Sachs Large Cp Val Insghts A
MGFLX10.42N/A
N/A
MassMutual Global Adm
NQCFX28.23N/A
N/A
NorthQuest Capital
RGGYX26.29N/A
N/A
Victory RS Global Y

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with CELC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+4.30%
CELC - RAPP
44%
Loosely correlated
+167.18%
OCUL - RAPP
42%
Loosely correlated
-1.06%
DNLI - RAPP
41%
Loosely correlated
-0.29%
DAWN - RAPP
39%
Loosely correlated
-1.80%
MNMD - RAPP
39%
Loosely correlated
-0.82%
More